Oncology and Therapy

Oncology and Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad, dedicated to the publication of high-quality clinical, observational, real-world, patient care, and health outcomes research around the discovery, development, and use of therapeutics and interventions across all areas of oncology. The key features of the journal are:

Rapid publication: The journal aims for a 2-week peer review, 3-4 weeks from acceptance to online.
Open access: All articles published open access (CC-BY-NC)
Inclusivity: All scientifically sound research considered be it positive, confirmatory or negative data. Research is considered from pre-clinical, clinical phase, real-world and health economics outcomes studies. Submissions are welcomed whether they relate to an international or a country-specific audience.
Personal service: The journal’s team will re-format articles and upload submissions on behalf of authors, if necessary.
Digital Features and Plain Language Summaries: These peer-reviewed features are welcomed to help enhance the educational value of a manuscript (for more information see “Author Information – Guidelines for digital features and plain language summaries” under “Submission guidelines”).
Publication fees: Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of £4900/€5750/$7400. There is an additional fee for podcast articles. The journal will consider fee discounts and waivers for developing countries and this is decided on a case-by-case basis. If you would like to request a discount or waiver please do so either ahead of submission or at the very start of the submission process. Requests made after this stage will not be considered.
Contact: For more information about the journal, including pre-submission enquiries, please contact lydia.alborn@springer.com.